Nykode Company
Nykode Therapeutics is a clinical-stage biopharmaceutical platform that develops novel vaccines against HPV-induced malignacies
Last Funding Date:
2016-12-16
Last Funding Type:
Venture Round
Investors Number:
5
Industry:
Tumor-Specific Antigens
Founded Date:
2007-01-01
Employee Number:
11-50
Total Funding:
36596103
Headquarters:
Oslo, Oslo, Norway
Estimated Revenue:
Less than $1M
Funding Status:
Venture